Investing.com - Itamar Medical reported on Tuesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Itamar Medical announced earnings per share of $-0.29 on revenue of $12.56M. Analysts polled by Investing.com anticipated EPS of $-0.1567 on revenue of $11.81M.
Itamar Medical shares are down 9.72% from the beginning of the year and are trading at $17.93 , down-from-52-week-high.They are under-performing the Nasdaq which is up 15.3% from the start of the year.
Itamar Medical follows other major Healthcare sector earnings this month
Itamar Medical's report follows an earnings beat by Merck ADR on Thursday, who reported EPS of $0.5304 on revenue of $5.77B, compared to forecasts EPS of $0.4897 on revenue of $5.63B.
Hoya Corp had beat expectations on July 29 with second quarter EPS of $1.02 on revenue of $1.44B, compared to forecast for EPS of $0.8576 on revenue of $1.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar